Summary
This NIH funding opportunity (RFA-HL-26-020) under the Catalyze program supports medical device prototype optimization in the product definition phase. The R33 mechanism funds late-stage research and development activities focused on refining and optimizing medical device prototypes, explicitly excluding clinical trials. Issued by the National Heart, Lung, and Blood Institute (NHLBI) within NIH/HHS, this opportunity is open from November 2024 through December 2027.